Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chen, Jie ^a   Wei, Deying ^a   Zhao, Yueran ^a   Liu, Xiaoyan ^b   Zhang, Jie ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS, CD34; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MICROVESSELS; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893580392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078783     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Brun JL, Feyler A, Chene G, Saurel J, Brun G, et al (2000) Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 78: 21-7. (Pubitemid 30439473)
3. Cho KR, Shih Ie M (2009) Ovarian cancer. Annu Rev Pathol 4: 287-313.
4. Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9: 415-28.
5. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331: 1559-64.
6. Coticchia CM, Yang J, Moses MA (2008) Ovarian cancer biomarkers: current options and future promise. J Natl Compr Canc Netw 6:795-802.
7. de Vega S, Iwamoto T, Yamada Y (2009) Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66:1890-1902.
8. Gallagher WM, Currid CA, Whelan LC (2005) Fibulins and cancer: friend or foe? Trends Mol Med 11:336-340. (Pubitemid 40984716)
9. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, et al (2002) Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21(7):1097-1107. (Pubitemid 34174522)
10. Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, et al (2003) Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 88(6):871-878. (Pubitemid 36520874)
11. Bardin A, Moll F, Margueron R, Delfour C, Chu ML, et al (2005) Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology 146(2):760-768. (Pubitemid 40129832)
12. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, et al (2011) Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog 50(8):571-579.
13. Cheng YY, Jin H, Liu X, Siu JM, Wong YP, et al (2008) Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer 99(12):2083-2087.
14. Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, et al (2007) Downregulation of several fibulin genes in prostate cancer. Prostate 67(16):1770-1780. (Pubitemid 350228729)
15. Xie L, Palmsten K, MacDonald B, Kieran MW, Potenta S, et al (2008) Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) 233(2):155-162. (Pubitemid 351231547)
16. Law EW, Cheung AK, Kashuba VI, Pavlova TV, Zabarovsky ER, et al (2012) Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene 31(6):728-738.
17. Yi CH, Smith DJ, West WW, Hollingsworth MA (2007) Loss of fibulin-2 expression is associated with breast cancer progression. Am J Pathol 170(5):1535-1545. (Pubitemid 47339299)
18. Schluterman MK, Chapman SL, Korpanty G, Ozumi K, Fukai T, et al (2010) Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS. Dis Model Mech 3(5-6):333-342.
19. Hu Z, Ai Q, Xu H, Ma X, Li HZ, et al (2011) Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. Urol Oncol 29(4):430-435.
20. Yue W, Sun Q, Landreneau R, Wu C, Siegfried JM, et al (2009) Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.Cancer Res 69(15):6339-6346.
21. Seeliger H, Camaj P, Ischenko I, Kleespies A, De Toni EN, et al (2009) EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res 7(2):189-198.
22. Song EL, Hou YP, Yu SP, Chen SG, Huang JT, et al (2011) EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo. Gynecol Oncol 121(1):174-180.
23. En-lin S, Sheng-guo C, Hua-qiao W (2010) The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis. Gynecol Oncol 117(3):417-422.
24. Hu B, Thirtamara-Rajamani KK, Sim H, Viapiano MS (2009) Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 7(11):1756-1770.
25. Hwang CF, Chien CY, Huang SC, Yin YF, Huang CC, et al (2010) Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol 222(4):367-379.
26. Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, et al (2009) Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 124(7):1727-1735.
27. Hu Y, Pioli PD, Siegel E, Zhang Q, Nelson J, et al (2011) EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer 28;10:123.
28. Kim EJ, Lee SY, Woo MK, Choi SI, Kim TR, et al (2012) Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation. Int J Oncol 40(2):402-8.
29. Omasu F, Nakano Y, Ichiki T (2005) Measurement of the electrophoretic mobility of sheep erythrocytes using microcapillary chips. Electrophoresis 26:1163-1167 (Pubitemid 40514807)
30. Chen J, Zhang J, Zhao Y, Li J, Fu M (2009) Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones. J Cancer Res Clin Oncol 135: 909-17.
31. Chen J, Liu X, Zhang J, Zhao Y (2012) Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.J Cell Physiol 227(11):3629-38.
32. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, et al (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84 (24):1875-87. (Pubitemid 23004615)
33. Albig AR, Neil JR, Schiemann WP (2006) Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66(5):2621-9.
34. Chen L, Sun B, Zhang S, Zhao X, He Y, et al (2009) Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma. Oncol Rep 21(4): 917-23.
35. Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, et al (2012) Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 367(15):1417-27.